Neothetics’ Belly-Busting Shot Lipo-202 Enters Phase 3 Trials
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
A new analysis points to aging patients, rising med-spa volume, and next-generation HA and biostimulatory formulas as drivers behind the projected jump to an $8.45B global fillers market.